首页 / 资料库 / 文献详情

[Determination of oxidation-reduction level in patients with rheumatoid arthritis].

Wencan CaiHai WangRuiqing LiLin Gao

2005PubMedMedicine被引 3

出版方页面 →

摘要

OBJECTIVE: To examine the oxidation or reduction products in patients with rheumatism arthritis (RA), and investigate the relationship between oxidation or reduction products and occurrence and development of RA. METHODS: The serum levels of total ascorbic acid (TAA), dehydroascorbic acid (DHAA)/TAA, vitamin E, advanced oxidation protein products (AOPP) and malondialdehyde (MDA) were detected by high-performance liquid chromatography with electrochemical detection in 83 RA patients and 30 healthy adults. Correlation analysis of AOPP, MDA and hs-CRP was performed. RESULTS: Compared with normal control group, significantly higher serum MDA, DHAA/TAA, and AOPP levels were detected in RA patients (P<0.05), but vitamin E showed no significant difference (P<0.05). Linear regression analysis showed that MDA (P<0.01) was positively but AOPP (P>0.05) negatively correlated to hs-CRP. CONCLUSIONS: Oxidation or reduction products in serum of RA patients increases significantly, which may be an important mechanism for the occurrence and development of RA. Serum AOPP and MDA levels can reflect the oxidation status in RA patients.

引用本文(GB/T 7714)

Wencan Cai, Hai Wang, Ruiqing Li, 等. [Determination of oxidation-reduction level in patients with rheumatoid arthritis].[J]. PubMed, 2005.

引文网络

参考文献与被引分析加载中…

本站仅收录题录与摘要供学习参考,全文版权归属出版方;如有侵权请联系我们删除。